190A.T · Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ
Japan · RS rating 2 · As of 2026-10-14
| Price | 56.00 JPY |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 3 / 3 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 10 / 15 |
| Industry group (rank) | Pharmaceutical (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.5% |
| Market cap (USD) | $27.0M |